J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Vol 232, Issue 3 pp 597-608
Copyright © 1973 by The Physiological Society
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, G. F.
Right arrow Articles by Rogers, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, G. F.
Right arrow Articles by Rogers, H. J.

Further effects of chlorpromazine on the hexose permeability of the human erythrocyte

G. F. Baker and H. J. Rogers

1. The effect of chlorpromazine on hexose transfer across the human erythrocyte membrane was investigated by optical and isotopic techniques in intact erythrocytes.

2. Chlorpromazine produces two phases of inhibition of glucose exit at 17° C in both types of experiment.

3. Glucose exchange flux shows a much smaller decrease in flux rate at the same concentrations of chlorpromazine at 17° C.

4. Sorbose and glucose entry at 36° C show a similarly complex inhibition by chlorpromazine. The inhibitor constant (Ki) for these effects with the two sugars is similar.

5. An Arrhenius plot shows that the average energy change for the reaction of the carrier with chlorpromazine is -46 kJ mole-1 and suggests that a drug-induced conformational change in the carrier may occur.

6. These findings require models of hexose permeation to contain separate terms in their kinetics for net and exchange fluxes and the predictions of one such model have been compared with the experimental results.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 The Physiological Society.